31505-42-7

Basic information

• Product Name: 2-[(2-carboxybenzoyl)amino]-2-deoxyhexopyranose
• CAS NO: 31505-42-7
• Molecular Formula: C₁₄H₁₇NO₈
• Molecular Weight: 327.2867
• Mol File: 31505-42-7.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 718.1°C at 760 mmHg
• Flash Point: 388.1°C
• Density: 1.63g/cm³
• Vapor Pressure: 1.21E-21mmHg at 25°C
• Refractive Index: 1.671
• CAS DataBase Reference: 2-[(2-carboxybenzoyl)amino]-2-deoxyhexopyranose(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[(2-carboxybenzoyl)amino]-2-deoxyhexopyranose(31505-42-7)
• EPA Substance Registry System: 2-[(2-carboxybenzoyl)amino]-2-deoxyhexopyranose(31505-42-7)

Safety Data

• Hazardous Substances Data: 31505-42-7(Hazardous Substances Data)

Usage

General Description

2-[(2-carboxybenzoyl)amino]-2-deoxyhexopyranose is a chemical compound with the molecular formula C13H15NO8. It is a derivative of the hexose sugar molecule and contains a carboxybenzoyl group and an amino group. 2-[(2-carboxybenzoyl)amino]-2-deoxyhexopyranose is often used in synthetic organic chemistry as a building block for the creation of more complex molecules. It has also been studied for its potential pharmacological properties, particularly in the development of new drugs for the treatment of various diseases. Additionally, it has shown promise in the field of biomedical research for its ability to modify and control the properties of biomolecules.

Upstream product

• 85-44-9 phthalic anhydride 
• 14131-62-5 D-glucosamine hydrochloride 
• 1078691-95-8 (+)-D-glucosamine hydrochloride 

Downstream Products

• 10022-13-6 1,3,4,6-tetra-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranose 
• 123212-53-3 ethyl 3-O-benzyl-4,6-O-benzylidene-2-deoxy-2-N-phthalamido-1-thio-β-D-glucopyranoside 
• 177358-18-8 ethyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl-(1->4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopryanoside 
• 85193-94-8 methyl β-D-galactopyranosyl-(1->4)-2-acetamido-3,6-di-O-benzyl-2-deoxy-β-D-glucopyranoside 
• 151342-40-4 methyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl-(1->4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside 
• 115533-35-2 ethyl 3,6-di-O-benzyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 
• 100638-50-4 methyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl-(1->4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside 
• 129090-85-3 methyl β-D-galactopyranosyl-(1->4)-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside 
• 97242-79-0 methyl 3,6-di-O-benzyl-2-deoxy-2-N-phthalimido-β-D-glucopyranoside 
• 130539-43-4 ethyl 2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 
• 99409-33-3 ethyl 4,6-O-benzylidene-2-deoxy-2-N-phthalamido-1-thio-β-Dglucopyranoside 
• 99409-32-2 ethyl-3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 
• 136198-40-8 methyl-N,N'-diacetyl-β-chitobioside 

Relevant articles and documents

Monophosphate A conjugated-Tn anti-tumor vaccine and application thereof

The invention provides a monophosphate A conjugated-Tn anti-tumor vaccine. The monophosphate A conjugated-Tn anti-tumor vaccine is a compound shown in a formula (I), namely Y-L-X(I). The monophosphateA conjugated-Tn anti-tumor vaccine is characterized in that a compound of the second generation of TLR4 ligand I of wholly new structure in the formula (I) is used for replacing MPLA (modified polylactic acid) and coupling with a compound (Tn) with clinical development potential in a formula (II), so as to obtain the two-component vaccine with a clear structure and a stronger anti-tumor function;the anti-tumor application prospect is better.

ANTIBODY CONJUGATES AND METHODS OF MAKING THE ANTIBODY CONJUGATES

Described herein are antibody conjugates and methods of making antibody conjugates.

THE PHTHALATION OF 2-AMINO-2-DEOXY-D-GLUCOSE AND N-METHYL-1-AMINO-1-DEOXY-D-GLUCITOL; CONVERSION OF THE PRODUCTS TO ORGANOTIN DERIVATIVES. A READY MIGRATION OF ACETYL FROM OXYGEN TO NITROGEN UNDER NEUTRAL CONDITIONS

N-Phthalation of 3-amino-3-deoxy-D-glucose was followed by replacement of the acidic proton by tributyl- and triphenylstannyl groups.A similar reaction with 1-(methylamino)-1-deoxy-D-glucitol failed and successive treatment with benzyl chloroformate and acetic anhydride followed by catalytic hydrogenation showed that a 1,4-O->N acetyl migration had occured.Phthalation and stannylation succeeded under different conditions.